• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    Cholera Vaccine Campaign in Haiti Meets Opposition

    By Jenny Lei Ravelo // 10 November 2011
    Cholera patients lie on mats at a crowded hospital in Haiti. Photo by: Sophia Paris / UN

    Partners in Health and nonprofit health organization Gheskio Center’s newest planned assault against the deadly cholera virus in Haiti is being met with opposition by public health experts.

    The health care organizations are pushing for the use of Shanchol, a new cholera vaccine made by the French pharmaceutical company Sanofi Pasteur and approved for use by the World Health Organization, to combat the disease.

    Public health experts, however, cast doubts on the success of the campaign, saying it will only inoculate 1 percent of the country’s population. They also question the money to be spent on the vaccines, which would total $870,000. They believe it is best to spend the money instead on water and sanitation measures.

    Partners in Health co-founder and U.N. special envoy Dr. Paul Farmer, who has been working for more than 20 years to improve public health, dismissed the health experts’ sentiments.

    “It’s been a joke to focus on how much it costs,” Farmer said. “The Haitian cholera epidemic is the largest in the world.”

    Meanwhile, Jon Weigel, Farmer’s researcher, countered concerns on the vaccine’s follow-up dose and offered the Gardasil vaccination program against human papillomavirus as an example. The program, which was launched in 2009 to combat cervical cancer, required three follow-up doses over a period of six months. It reached a success rate of 75 percent.

    He added that efforts to develop Haiti’s water and water systems will also not be ignored.

    “We’re not doing this at the exclusion of water and sanitation,” he said.

    The campaign is being supported by Haiti’s new leaders — President Michel Martelly and Prime Minister Garry Conille. Still, others are skeptical.

    “Everybody thinks it’s going to do some good,” said Richard Garfield, a professor of public health and nursing at Columbia University. “But it’s hard to specify how much good and benefit will come out of that …”

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Sexual and reproductive health rightsGavi cervical cancer campaign aims to reach African girls through sports

    Gavi cervical cancer campaign aims to reach African girls through sports

    Devex CheckUpDevex CheckUp: Countries are told to boost domestic health spending. But how?

    Devex CheckUp: Countries are told to boost domestic health spending. But how?

    Global healthHow Gavi is reaching ‘zero-dose’ children in conflict areas

    How Gavi is reaching ‘zero-dose’ children in conflict areas

    Global HealthUS funding cuts risk spread of hepatitis

    US funding cuts risk spread of hepatitis

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      USAID's humanitarian bureau is under pressure and overstretched
    • 5
      The UN's changing of the guard
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement